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Memory reconsolidation impairment using the β-noradrenergic receptor blocker
propranolol is a promising novel treatment avenue for patients suffering from pathogenic
memories, such as post-traumatic stress disorder (PTSD). However, in order to better
inform targeted treatment development, the effects of this compound on memory
need to be better characterized via translational research. We examined the effects
of systemic propranolol administration in mice undergoing a wide range of behavioral
tests to determine more specifically which aspects of the memory consolidation and
reconsolidation are impaired by propranolol. We found that propranolol (10 mg/kg)
affected memory consolidation in non-aversive tasks (object recognition and object
location) but not in moderately (Morris water maze (MWM) to highly (passive avoidance,
conditioned taste aversion) aversive tasks. Further, propranolol impaired memory
reconsolidation in the most and in the least aversive tasks, but not in the moderately
aversive task, suggesting its amnesic effect was not related to task aversion. Moreover,
in aquatic object recognition and location tasks in which animals were forced to behave
(contrary to the classic versions of the tasks); propranolol did not impair memory
reconsolidation. Taken together our results suggest that the memory impairment
observed after propranolol administration may result from a modification of the
emotional valence of the memory rather than a disruption of the contextual component
of the memory trace. This is relevant to the use of propranolol to block memory
reconsolidation in individuals with PTSD, as such a treatment would not erase the
traumatic memory but only reduce the emotional valence associated with this event.
Keywords: PTSD, consolidation, reconsolidation, propranolol, noradrenergic system, aversive memory,
emotional valence
Frontiers in Behavioral Neuroscience | www.frontiersin.org 1 March 2016 | Volume 10 | Article 49
Villain et al. Propranolol, Consolidation and Reconsolidation
INTRODUCTION
A newly acquired memory trace is initially labile and undergoes
a consolidation process required to maintain it stable overtime
(McGaugh, 1966, 2000). However, reactivation of a previously
consolidated memory may render it labile again, introducing a
need for restabilization called memory reconsolidation (Nader
et al., 2000; Sara, 2000). Interfering with the reconsolidation
processes impairs subsequent re-storage, inducing so-called
amnesia in animals (for a systematic review, see Besnard
et al., 2012). Combining targeted memory retrieval with a
reconsolidation impairing agent may thus disrupt unwanted
memories, and serve as treatment for individuals suffering from
a pathogenic memory, such as in post-traumatic stress disorder
(PTSD), which involve impairment of memory processes in their
pathophysiology (Brewin, 2011).
The noradrenergic system is critical in modulating memory
processes, and stimulation of β-noradrenergic receptors
has been found to facilitate emotional and non-emotional
memory consolidation (McGaugh, 2004; Roozendaal et al.,
2008) as well as reconsolidation (De
‘
biec et al., 2011).
Noradrenergic enhancement, and specifically enhancement
of the β-noradrenergic signaling during memory reconsolidation
has been suggested to increase the strength of emotionalmemory,
and has thus been suggested to contribute to the persistence of
traumatic memories (De
‘
biec et al., 2011). Moreover, a hyper-
noradrenergic state has been implicated in the pathophysiology
of PTSD (Strawn and Geracioti, 2008). In this context, the
β-noradrenergic receptors antagonist propranolol has generated
considerable interest as an agent for dampening emotional and
traumatic memories in healthy humans and in individuals with
PTSD.
In healthy humans, propranolol has been found to impair
the consolidation of emotional items memory (Cahill et al.,
1994; van Stegeren et al., 2005), and of fear memory in
a contextual fear conditioning test (Grillon et al., 2004).
Administered concurrently to fear conditioned memory
reactivation, propranolol has been shown to reduce subsequent
fear related to the cue, leaving the declarative memory associated
to the cue intact (Kindt et al., 2009). Despite a few negative
studies (e.g., Bos et al., 2014), the majority of them reported
successful propranolol-induced disruption of reconsolidation,
that persisted at least 1 month and resisted to fear reinstatement
(Soeter and Kindt, 2010, 2012; for a meta-analytic review, see
Lonergan et al., 2013).
From a therapeutic perspective, propranolol has been
tested for phobia (Soeter and Kindt, 2015), substance abuse
(Lonergan et al., 2015) and more interestingly for PTSD.
Initially, propranolol was used to prevent the consolidation
of the traumatic memories in acutely traumatized individuals.
Two studies reported a reduction of PTSD rate and symptoms
in patients (Pitman et al., 2002; Vaiva et al., 2003). However,
targeting the consolidation processes proved to be impractical
because of the short time-window of action for blocking
consolidation in the aftermath of trauma, and because
not all trauma-exposed individuals will develop PTSD. A
way to get around these issues is to act during memory
reactivation when the memory trace is labile again. Thus,
using a randomized controlled design, Brunet et al. (2008)
administered a single day of propranolol following traumatic
memory reactivation and found that this treatment reduced,
1 week later, physiologic responses to mental imagery of
the traumatic event in PTSD patients. However, a recent
study failed to replicate this beneficial effect with a single
reactivation session associated to propranolol (Wood et al.,
2015). In a series of three open label trials, a PTSD remission
rate of up to 71% was observed after six sessions of trauma
recollection under the influence of propranolol (Brunet
et al., 2011), with significant reduction in physiological
responding including at the 6-month follow-up (Brunet
et al., 2014).
While blockade of memory reconsolidation thus appears as
a promising treatment approach to further test and explore,
many important questions remain unanswered. For example,
the nature and extent of the memory impairment remain to
be clarified so as to effectively and specifically target memories
involved in the pathophysiology of disorders, without affecting
others. In particular, the types of memory (e.g., traumatic,
contextual) on which propranolol exerts its effects are still
unknown. Translational research requires, in parallel to the
human clinical research, basic research to be conducted in
animals to clarify the effects of reconsolidation impairment with
propranolol.
The literature remains unclear and often contradictory
regarding the amnesic effects of propranolol in animal models.
Some research reported that propranolol impaired consolidation
in tasks as varied as the passive avoidance (Gallagher et al.,
1977), the Morris water maze (MWM; Cahill et al., 2000) or
the object recognition (Conversi et al., 2014), while others using
the same tasks failed to do so (Lalumiere et al., 2004; Dornelles
et al., 2007; Row and Dohanich, 2008; Okamura et al., 2011;
Palotai et al., 2014). Data regarding the effects of propranolol on
memory reconsolidation have been more consistently reported
than its effect on consolidation. Administration of propranolol
at the time of retrieval has thus been found to dampen contextual
and auditory fear memory (De
‘
biec and LeDoux, 2004, 2006;
Muravieva and Alberini, 2010), spatial memory in a radial
maze test (Przybyslawski et al., 1999), and appetitive memories
(Bernardi et al., 2006; Diergaarde et al., 2006; Robinson and
Franklin, 2007). However, some studies failed to report an
amnesic effect associated with propranolol administration in
passive avoidance (Muravieva and Alberini, 2010), contextual
conditioning (Gazarini et al., 2013), and object recognition
(Maroun and Akirav, 2008). These conflicting results might be
due to differences in methods and procedures between species or
strain of animals, and in doses of drug or routes of administration
(systemic vs. central into a brain region).
Thus, to date, the effects of propranolol on human and animal
memories remain to be clarified. It is becoming increasingly
important to understand the effect of propranolol on various
types of memories in order to successfully guide treatment
development for mental disorders including PTSD.
In the present study, we therefore sought to determine
which aspects of memory were affected by propranolol by
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using a broad range of behavioral tests performed in the
same lab with the same strain of mice so as to compare
directly and unambiguously in the same conditions all behavioral
results. These tasks differ in their spatial, associative, of
aversive characteristics ranging from very aversive (passive
avoidance, conditioned taste aversion), moderate (MWM) to
non aversive task (object recognition and object location). We
found that propranolol-induced amnesia was not related to
the degree of task aversiveness or the spatial or associative
nature of the tasks. To further clarify our results, we
then developed a series of new behavioral experiments,
in order to examine independently memory problem (i.e.,
contextual amnesia) and emotional state (i.e., memory valence,
detachment). In these new procedures, in which animals were
forced to behave, propranolol had no effect on contextual
memory.
Finally, we also sought to compare the propranolol-induced
amnesia in consolidation vs. reconsolidation within the same
experimental conditions. As propranolol acts by blocking the
activation of β-noradrenergic receptors by noradrenaline, in
these studies, it will be possible to know if endogenous
noradrenaline and specifically β-noradrenergic signaling play the
same critical role in memory consolidation and reconsolidation,
and if this implication is the same whatever be the tasks
used. In different studies, propranolol was found to induce
amnesia only if injected during the memory reconsolidation,
but not during initial memory consolidation in very aversive
learning as the passive avoidance task (Przybyslawski et al.,
1999) or the auditory fear conditioning task (De
‘
biec and
LeDoux, 2004). We complemented these experiments with
other aversive tasks as well as with non-aversive learning
task, and found this differential effect of propranolol on
reconsolidation and consolidation, only in highly aversive
task.
MATERIALS AND METHODS
Animals
A total of 368 CD1male mice (IFFA CREDO, Lyon, France) were
housed in groups of five in standard breeding cages placed in a
rearing room at a constant temperature under diurnal conditions
(light-dark: 08:00-20:00), with food and water ad libitum. Every
possible effort was made to minimize animal suffering and
all experiments were performed in strict accordance with the
recommendations of the European Union (86/609/EEC) and
the French National Committee (87/848). All animal procedures
were approved by the University Animal Care Committee of
Toulouse (FRBT C2EA-01).
Behavioral Testing
The number of mice per group ranged between 8 and 14. Three-
to four-months old mice were familiarized with the experimenter
and all experiments were performed during the light phase. All
the behavioral groups were independent, i.e., each mouse was
tested in only one experiment.
An informed choice of behavioral procedures is essential
and we chose only paradigms well suited to study both the
initial consolidation and the subsequent reconsolidation phase
given their rapid acquisition. For the reconsolidation studies,
we chose well established behavioral procedures and reactivation
protocols previously used in different memory reconsolidation
studies. Moreover, an essential control in reconsolidation studies
involves the administration of the drug treatment without the
reactivation session. Thus, each time we found a propranolol
effect, we added a control experiment to determine if the
propranolol-induced reconsolidation impairment was specific to
an actively retrieved memory. To achieve that, we used exactly
the same protocol as in the reconsolidation experiments except
that mice did not undergo reactivation and that injections were
performed in the animal room.
Mice were subjected to the following behavioral tests.
Passive Avoidance Task
The apparatus consisted of a rectangular box divided into
an illuminated ‘‘safe’’ compartment and a dark ‘‘shock’’
compartment. Subjects were individually placed into the
illuminated compartment and when they entered completely
inside the dark compartment, a foot shock (280 µA for 2 s) was
administered. Subsequently, the mouse was placed in its home
cage. For the consolidation procedure, retention was measured
24 h later by placing the mouse in the light compartment and
measuring the latency to enter the dark compartment and the
percentage of avoidance of the dark side. For the reconsolidation
procedure, to reactivate memory, 24 h after acquisition, we
placed the mouse during 60 s into the illuminated compartment
(open door). The entry into the dark compartment during
reactivation was chosen as an exclusion criterion and for this
reason three mice were removed from the experiments. The
probe test (PT) was realized 24 h later (Jobim et al., 2012).
Conditioned Taste Aversion Test (CTA)
The mice were initially deprived of water for 24 h and then
habituated in a new cage to drink water from a graduated
bottle for 30 min/day for 6 days (days 1–6). After a stable
water consumption baseline was reached, the animals were
randomly divided into treatment groups and acquisition of CTA
was performed. For conditioning (day 7), the water bottle was
replaced by a bottle containing a 1% saccharin solution and
the mice were allowed to drink for 30 min. Thirty minutes
after completion of saccharin intake, the animals were injected
intraperitoneally with lithium chloride (LiCl; 125 mg/kg) that
induces nausea and produces robust CTA (Miranda et al.,
2003; Tuerke et al., 2012). During the first hour following the
injection, the behavior of the mice in their home cage was
observed to control whether nausea had occurred, and then a
normal behavior was recovered within 1 h. In our experimental
conditions, the gastric malaise was observed in all mice treated
withNaCl or propranolol and thismalaise was only visible during
10–20 min after the injection. As the duration of malaise was
short, propranolol was always active during the consolidation of
the CTA. In the choice test 1 day later (day 8), mice were placed
back into the same cage and had access to bottles containing
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either water or saccharin for a period of 30 min. The volume
drunk in each bottle was recorded.
For the reconsolidation procedure, the habituation and
acquisition phases were identical to the consolidation procedure
(days 1–7). For the next 3 days after acquisition (days 8–10),
mice received water as during the habituation phase. Twenty-
four hours later (day 11), to reactivate memory, we placed the
mouse for 1 min into the cage with the bottle of saccharin (Bahar
et al., 2004). The choice test took place 24 h after reactivation
(day 12).
Morris Water Maze Test (MWM)
Spatial memory testing was conducted as described (Florian
and Roullet, 2004). Briefly, mice were introduced to a circular
pool (110 cm in diameter) filled with water made opaque.
Subjects were trained to locate the hidden platform, which was
submerged 0.5 cm below the water. Onemass-training procedure
was performed. The procedure included one training session
composed of four blocks, each consisting of three consecutive
trials. The phase between consecutive blocks was 15–20min long,
during which the mouse was returned to its home cage. The total
duration of this training phase do not exceed 1 h 20 min. For
the consolidation procedure, 24 h post acquisition, memory was
assessed during a single 1 min PT in the absence of the platform.
The number of annulus crossings, defined as the number of times
a mouse crossed an ideal circle (14 cm diameter) located at the
original platform location and the three equivalent areas in each
of the other quadrants were analyzed. The number of annulus
crossings could reveal the strategy used whilst searching for the
platform, while the number of target annulus crossings would
determine if mice had learned the target’s location.
For the reconsolidation procedure, 24 h after training, a
reactivation trial (R) consisting in an additional learning trial,
was performed (De Jaeger et al., 2014). The PT took place 24 h
after reactivation.
In the MWM, the level of stress is dependent on the water
temperature. In the first experiment, the temperature of the
water is relatively high (23 ± 1◦C) and in this condition, MWM
might be considered as a mildly stressful situation. In the second
experiment, the temperature of the water is low (19 ± 1◦C) and
MWMmight be considered as a highly stressful situation (Sandi
et al., 1997).
Object Recognition Task
The procedure consisted of three different phases as described
previously (Goodman et al., 2010). Briefly, a familiarization phase
in which each mouse was placed in the empty square open-field
for 10 min. A sample phase, 24 h later, in which two identical
objects were placed in the middle of the open-field. The test
phase, for the consolidation procedure, 24 h later whereby mice
were reintroduced into the arena and exposed to two objects, a
familiar object and a novel object, to test recognition memory.
The percent time spent exploring the novel object was calculated
as a preference index to measure novel object recognition. For
the reconsolidation procedure, 24 h after training, a 2 min
reactivation phase, identical to the sample phase, was performed
(Rossato et al., 2007).
Object Location Task
The same open-field with the same environment was used as that
of the object recognition task. Similar procedures were employed
except that for the test phase, one of the two identical objects was
moved to a novel location (Goodman et al., 2010). The percent
time spent exploring the displaced object was calculated as a
preference index to measure spatial memory.
Finally, two novel behavioral tests were specifically designed
for this study, the aquatic object recognition and object location
tasks.
Aquatic Object Recognition Task
Mice were introduced into the circular pool (23◦C) previously
described for the MWM, except that the distal cues were
removed. An object was suspended 13 cm above the 0.5 cm-
submerged platform. In this new behavioral task, the mouse had
to learn the association between the object and the presence
of the platform. One mass-training procedure composed of
four blocks of three consecutive trials was performed. The
total duration of this training phase do not exceed 1 h 20
min. For each block, platform and object were placed in a
different quadrant of the pool. Twenty-four hours after training,
a reactivation trial (R) consisting in an additional learning trial,
was performed. The PT took place 24 h after reactivation.
The platform was removed and the familiar object was placed
in the northern quadrant and a new object was placed in
the opposite quadrant. The mouse had to dissociate the two
objects as in the classic version of the object recognition task
and had to choose the location associated with the familiar
object. The number of annulus (a 14 cm diameter circle
located below the objects) crossings was analyzed and the
percent number of crossing below the familiar object was
calculated as a preference index to measure familiar object
recognition.
Aquatic Object Location Task
The same pool (23◦C) was used as that of the aquatic object
recognition task but this time some distal cues were added
in the environment. In this task, the mouse must also learn
the association between the object and the presence of the
platform. But in this new procedure, the platform is always in
the same place during the four blocks of three trials. Twenty-
four hours after training, a reactivation trial (R) consisting
in an additional learning trial, was performed. The PT took
place 24 h after reactivation. During this test, the platform was
removed and a second object, identical to the first one, was
placed in the opposite quadrant. The mouse had to differentiate
the two spatial locations as in the classic version of the object
location but this time, had to choose the old location to find the
platform. The number of annulus crossings was analyzed and
the percent number of crossing below the non-displaced object
was calculated as a preference index to measure familiar object
location.
Drug and Injections
DL-Propranolol, an antagonist of β-noradrenergic receptors that
crosses the blood-brain-barrier, obtained from Sigma-Aldrich
Frontiers in Behavioral Neuroscience | www.frontiersin.org 4 March 2016 | Volume 10 | Article 49
Villain et al. Propranolol, Consolidation and Reconsolidation
(France) was prepared in 0.9% saline (NaCl) and injected
intraperitoneally at a dose of 10 mg/kg (Przybyslawski et al.,
1999; Conversi et al., 2014). NaCl and propranolol were both
administered at a volume of 10 mL/kg. Mice received injections
of propranolol or NaCl immediately after training for the
consolidation procedure except for the CTA test in which the
drugs were injected 25 min after the presentation of saccharin
and therefore 5min before LiCl injection. For the reconsolidation
procedure, mice received injections of propranolol or NaCl just
after reactivation, or the day following learning for the no-
reactivation procedure. The memory test took place 24 h after
injection. Consequently, animals were never tested under the
influence of propranolol but the day after injection, when the
drug was no longer present in the organism.
Statistical Analysis
SYSTAT 9.0 statistical software package was used for data
analysis. The results were expressed as mean ± SEM and
analyzed using one or two-way analyses of variance (ANOVAs),
or repeated measures ANOVAs when appropriate. Partial eta
squared (η2p) was reported for each significant comparison as a
measure of effect size for significant results in ANOVAs. The
alpha level of significance was set at 0.05 (two-sided tests). Post
hoc multiple comparison tests were carried out when allowed,
using Tukey’s Honestly Significant Distance (HSD) test. For the
passive avoidance task, the percentage of avoidance of the dark
compartment was analyzed between groups using χ2 tests.
RESULTS
Passive Avoidance
The baseline latency to enter the dark compartment during
acquisition (i.e., before treatment), did not differ between the
two groups of mice for the consolidation [NaCl: 17.3 s ±
3.1; Propranolol: 15.4 s ± 1.9; F(1,26) = 0.262; p = 0.613],
reconsolidation [NaCl: 19.2 s ± 4.5; Propranolol: 18.5 s ± 6.4;
F(1,20) = 0.008, p = 0.928] and no-reactivation [NaCl: 15.5 s ±
4.0; Propranolol: 19.5 s ± 12.018; F(1,15) = −1.312; p = 0.209]
procedures.
During the test, in the memory consolidation procedure
(Figure 1A), there was no effect of treatment on the latency to
enter the dark side of the box [F(1,26) = 0.038; p = 0.846] and
on the percentage of avoidance of this dark side [χ2 = 0.158;
p = 0.691] as illustrated in Figures 1C,F. However, propranolol
injected after reactivation in the passive avoidance task
(Figure 1B) caused a marked performance decrement during the
test session (Figures 1D,G). Propranolol-injected mice exhibited
shorter latencies to enter the dark compartment during the
retention test [η2p = 0.433; F(1,16) = 12.203; p = 0.003] and
avoided less this aversive compartment than controls [χ2=
7.462; p = 0.006]. Moreover, propranolol administered without
any reactivation (Figures 1B,E,H) did not affect memory
performance [latencies: F(1,15) = 0.029; p = 0.867, avoidance:
χ2 = 0.017; p = 0.896] demonstrating an amnesic effect specific
to memory reconsolidation in this aversive task.
Conditioned Taste Aversion
During acquisition and reactivation, we did not find any
difference in liquid consumption between the two groups
of mice, for the consolidation [acquisition: F(1,12) = 1.687;
p = 0.218], reconsolidation [acquisition: F(1,14) = 0.578; p = 0.459;
reactivation: F(1,14) = 1.647; p = 0.220] and no-reactivation
[acquisition: F(1,14) =−0.260; p = 0.799] procedures. Thus before
treatment, the two groups of mice similarly learned this task.
In the consolidation procedure (Figures 2A,C), during
the choice test, an ANOVA revealed no treatment effect
[F(1,24) = 0.366; p = 0.551], no interaction between treatment and
liquid [F(1,24) = 0.113; p = 0.739], but an important preference
for water over saccharin [η2p = 0.796; F(1,24) = 93.843; p < 0.001].
In fact, mice consumed more water than saccharin among
control (p < 0.001), as well as among propranolol-treated mice
(p< 0.001).
In the reconsolidation procedure (Figures 2B,D), we also
obtained no main effect for treatment [F(1,28) = 0.005; p = 0.943]
and a global preference for water over saccharin [η2p = 0.327;
F(1,28) = 13.618; p < 0.001]. However, in this procedure, there
was an important treatment × liquid interaction [η2p = 0.245;
F(1,28) = 9.090; p = 0.005]. While there was a clear water
preference in control mice (p < 0.001), propranolol-injected
mice consumed similar quantities of water and saccharin
(p = 0.963). When memory was not reactivated before
propranolol injection (Figures 2B,E), mice strongly preferred
water [η2p = 0.894; F(1,24) = 203.440; p < 0.001]. We did
not observe any treatment effect [F(1,24) = 0.769; p = 0.389]
and interaction between treatment and liquid [F(1,24) = 2.917;
p = 0.101].
Once again, in these experiments, we found a propranolol
amnesic effect only on memory reconsolidation.
Morris Water Maze at 23◦C
Concerning the latency to find the hidden platform during
acquisition (Figure 3C), repeated measures ANOVA revealed
a significant session effect [η2p = 0.367; F(3,150) = 21.688;
p < 0.001] but no pre-treatment effect [F(1,50) = 0.072;
p = 0.789], nor procedure effect [F(1,50) = 1.515; p = 0.224].
These data confirmed that, in general, before treatment all
groups of mice similarly learned the position of the platform and
displayed the same level of performance during the four learning
sessions.
In the consolidation procedure (Figures 3A,D), propranolol
injection immediately after acquisition did not impair
retention during the PT 24 h later. In this experiment, a
two-way ANOVA revealed a significant quadrant effect
[η2p = 0.487; F(3,112) = 35.489; p < 0.001] but no treatment
effect (F(1,112) = 0.430; p = 0.513), and no treatment × quadrant
interaction [F(3,112) = 0.693; p = 0.558].
In the reconsolidation procedure (Figures 3B,E), an ANOVA
conducted on the latency to reach the platform during
reactivation did not find any pre-treatment effect [F(1,22) = 0.906;
p = 0.351]. During the PT, propranolol injections immediately
after reactivation did not impair retention during the PT 24 h
later. A two-way ANOVA revealed no significant effect between
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FIGURE 1 | Propranolol disrupts memory reconsolidation in the passive avoidance task. Schematic of the behavioral protocols for the consolidation
(A) and reconsolidation and no-reactivation (B) procedures. In the consolidation procedure (n = 14 per group), there was no memory deficit in propranolol-injected
mice for the latency (±SEM) to enter the dark box (C), nor for the percentage of avoidance of this aversive box (F). However, for the reconsolidation procedure,
propranolol-injected mice (n = 8) exhibited decreased memory performance relative to control mice (n = 10) (D,G). In the no-reactivation procedure,
propranolol-injected mice (n = 9) showed the same level of avoidance as control mice (n = 8) (E,H). ∗∗p < 0.01; ∗∗∗p < 0.001 NaCl vs. Propranolol.
NaCl- and propranolol-injected mice [F(1,88) = 0.025; p = 0.874]
on the total number of annulus crossings, but a significant
quadrant effect [η2p = 0.556; F(3,88) = 36.807; p < 0.001] and
no significant treatment × quadrant interaction [F(3,88) = 0.297;
p = 0.827], indicating that the profile of exploration of the
different quadrants was the same in the two groups of mice.
Because we used a relatively high water temperature (23◦C)
and the non-effect of propranolol might be linked to this low
magnitude stressful condition, we chose to replicate the MWM
with water at 19◦C, a more aversive procedure.
Morris Water Maze at 19◦C
Concerning the latency to find the hidden platform during
acquisition (Figure 3F), repeated measures ANOVA revealed a
significant session effect [η2p = 0.348; F(3,120) = 21.293; p< 0.001],
but no pre-treatment effect [F(1,40) = 0.049; p = 0.825], nor
procedure effect [F(1,40) = 0.266; p = 0.609], suggesting a similar
and good level of performance in the two groups.
During the PT for the consolidation procedure
(Figures 3A,G), propranolol injections did not impair memory
retention during the PT 24 h later. A two-way ANOVA revealed
a significant quadrant effect [η2p = 0.444; F(3,84) = 22.448;
p < 0.001] but no treatment effect [1,84 = 0.631; p = 0.429], and
no treatment× quadrant interaction [F(3,84) = 0.834; p = 0.479].
In the reconsolidation procedure (Figures 3B,H), an ANOVA
conducted on the latency to reach the platform during
the reactivation trial did not reveal any treatment effect
[F(1,18) = 0.312; p = 0.585]. A two-way ANOVA revealed
no significant effect between NaCl- and propranolol-injected
mice [F(1,72) = 0.126; p = 0.724] on the total number of
annulus crossings, but a significant quadrant effect [η2p = 0.488;
F(3,72) = 22.221; p < 0.001] and no significant treatment ×
quadrant interaction [F(3,72) = 0.141; p = 0.935] indicating
that the profile of exploration of the quadrants was the same
in the two groups of mice. With this new more aversive
MWM procedure, we obtained exactly the same results than
with the less aversive MWM procedure, i.e., no effect of
propranolol injection on the consolidation and reconsolidation
processes.
Taken together, our results suggest that propranolol
injections have no effect on spatial memory consolidation
and reconsolidation. In this experiment and in many others
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FIGURE 2 | Propranolol disrupts memory reconsolidation in the conditioned taste aversion task. Schematic of the behavioral protocols for the
consolidation (A) and reconsolidation and no-reactivation (B) procedures. Mean consumption (±SEM) of water (gray) and saccharin (white hachured) in the choice
test is represented. (C) In the consolidation procedure (n = 7 per group), a clear preference for the water was displayed for control but also for propranolol-injected
mice. (D) On the contrary, for the reconsolidation procedure (n = 8 per group), control mice avoided saccharin while propranolol-injected mice showed no preference
for water or saccharin. (E) In the no-reactivation procedure, there was not any memory deficit in propranolol-injected mice thus a preference for the water was
displayed in both group of mice (n = 8 per group). ∗∗∗p < 0.001 Water vs. Saccharin.
studies (Przybyslawski et al., 1999; De
‘
biec and LeDoux,
2004; Muravieva and Alberini, 2010), propranolol injection
blocked the reconsolidation memories of an aversive nature.
It is possible that the lack of effect was due to the MWM
being less aversive than passive avoidance or CTA. In other
words, it is possible that propranolol only exerts an effect
on aversive memory reconsolidation. In order to test this
hypothesis, we used two different non-aversive paradigms,
the object recognition task, a non-spatial and non-associative
task, and the object location task, a spatial but non-associative
task.
Object Recognition
During the training phase of the object recognition test, and thus
before treatment, we verified that there was no difference in the
total amount of time spent in exploration of the two identical
objects between propranolol-treated and saline control mice for
consolidation [NaCl: 160.5 s± 16.8; Propranolol: 172.6 s± 10.3;
F(1,34) = 0.030; p = 0.863], reconsolidation [NaCl: 118.38 s ±
12.01; Propranolol: 114.44 s ± 11.42; F(1,36) = 0.082; p = 0.776],
and no-reactivation [NaCl: 107.1 s ± 15.3; Propranolol: 112.7 s
± 19.8; F(1,28) = 0.090; p = 0.766] procedures.
Concerning the consolidation (Figure 4A), during the
retention test, as expected, control mice spent significantly more
time exploring the novel object as opposed to the familiar one,
so that the preference index was significantly different from
chance level (50%; 64.811 ± 2.90%; p = 0.001). In contrast, the
preference index for propranolol-injected mice was not different
from chance level (52.505 ± 1.17%; p = 0.086; Figure 4C). An
ANOVA conducted on the preference index revealed a treatment
effect [η2p = 0.491; F(1,16) = 15.406; p< 0.001].
In the reconsolidation procedure (Figure 4B), mice injected
with NaCl explored longer the new object than the familiar
one (65.450 ± 1.753%; p < 0.001) contrary to the propranolol-
injected mice (52.392 ± 1.14%; p = 0.096), suggesting that the
experimental animals did not recognize the object [η2p = 0.686;
F(1,17) = 37.081; p < 0.001; Figure 4D]. When no memory
reactivation was performed prior to treatment (Figure 4E),
propranolol did not influence exploration time [F(1,13) = 2.099;
p = 0.171]. Both NaCl (59.934 ± 3.963%; p < 0.001) and
propranolol-treated (63.470± 5.276%; p< 0.001) mice explored
longer the new object than the familiar object.
These results suggest that propranolol-injectedmicemay have
exhibited a non-spatial specific memory deficit in this non-
aversive and non-associative task.
Object Location
The total time spent during task acquisition exploring the objects
did not differ between propranolol-injected and saline control
mice in the consolidation [NaCl: 159.1 s ± 8.5; Propranolol:
158.1 s± 9.4; F(1,52) = 0.009; p = 0.927], reconsolidation [NaCl:
108.3 s± 7.2; Propranolol: 105.4 s± 6.8; F(1,52) = 0.035; p = 0.852]
and no-reactivation procedures of object location [NaCl: 138.4 s
± 26.7; Propranolol: 146.4 s± 27.4; F(1,32) = 0.087; p = 0.770].
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FIGURE 3 | Propranolol has no effect on memory reconsolidation in the Morris water maze (MWM) task. Schematic of the behavioral protocols for the
consolidation (A) and reconsolidation (B) procedures. 23◦C procedure (C–E). Throughout training sessions (C), mice learned equally well to locate the hidden
platform and exhibited decreasing latencies (±SEM) over blocks of trials in the two different behavioral procedures (consolidation and reconsolidation). The number
of annuli crossings (±SEM) during probe test (PT) in the consolidation (n = 15 per group; D) and reconsolidation (n = 12 per group; E) procedures are represented.
19◦C procedure (F–H). For this more aversive procedure with cold water, we found exactly the same results as in the 23◦C procedure i.e., mice learned equally well
to locate the hidden platform during training sessions (F), and all groups of mice showed similar preference for the target zone in the consolidation (NaCl: n = 10;
Propranolol: n = 14; G) and in the reconsolidation (NaCl: n = 9; Propranolol: n = 11; H) procedures. target vs. others, ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001.
Regarding the consolidation procedure (Figure 4A), control
mice spent significantly more time exploring the object
that had been displaced to a new location than the object
that had remained in a familiar location. Thus, control
mice exhibited an exploratory preference index that was
clearly different from chance level (50%; 60.935 ± 1.14%;
p < 0.001). In contrast, propranolol-treated mice exhibited
an exploratory preference index that was not significantly
different from chance (50.499 ± 0.951%; p = 0.609; Figure 4F).
ANOVA conducted on the preference index revealed a
significant treatment effect [η2p = 0.665; F(1,25) = 49.622;
p< 0.001].
For the reconsolidation procedure (Figure 4B), mice injected
with NaCl explored longer the displaced object than the non-
displaced one (60.156 ± 1.23%; p < 0.001) contrary to the
propranolol-injected mice (50.098± 1.70%; p = 0.609) indicating
that these experimental animals were not able to recognize
the displaced object [η2p = 0.484; F(1,25) = 23.485; p < 0.001;
Figure 4G]. This deficit was specific to reactivated memory as
in the non-reactivation procedure (Figure 4H), both groups of
mice recognized the displaced object (NaCl: 59.030 ± 6.257%;
p = 0.005; Propranolol: 59.980± 5.059%; p = 0.001), without any
influence of the treatment [F(1,15) = 0.146; p = 0.708].
In this non-aversive and non-associative task, propranolol-
injected mice exhibited a spatial memory deficit compared to
controls.
Aquatic Object Recognition
Concerning the latency to find the hidden platform during
acquisition for the aquatic object recognition test (Figures 5A,C),
repeated measures ANOVA revealed a significant session effect
[η2p = 0.513; F(3,60) = 21.105; p < 0.001] but no pre-treatment
effect [F(1,20) = 0.160; p = 0.694], nor session pre-treatment
interaction [F(3,60) = 1.545; p = 0.212]. An ANOVA conducted
on the latency to reach the platform during the reactivation trial
also revealed no treatment effect [F(1,20) = 0.008; p = 0.930]. Thus,
before treatment all groups of mice displayed the same level of
performance during the four learning sessions.
During PT (Figure 5E), all mice crossed significantly more
time below the familiar object than below the new object.
ANOVA conducted on the preference index revealed no
treatment effect [F(1,20) = 0.111; p = 0.743]. Control and
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FIGURE 4 | Propranolol impairs the memory reconsolidation in the object recognition and object location tasks. Schematics of the behavioral protocols
of the object recognition and object location tasks for the consolidation (A) and reconsolidation and no-reactivation (B) procedures. Performances are expressed as
the group mean (±SEM) preference index. The horizontal line represents equal exploration of the two objects. For the consolidation (n = 9 per group; C) and
reconsolidation (NaCl: n = 10; Propranolol: n = 9; D) procedures of the object recognition task, control mice spent significantly more time exploring the new object
than the familiar one. For the consolidation (NaCl: n = 13; Propranolol: n = 14; F) and reconsolidation (NaCl: n = 14; Propranolol: n = 13; G) procedures of the object
location task, NaCl-injected mice spent significantly more time exploring the displaced object than the non displaced one. Mice with propranolol injection during
consolidation or reconsolidation presented severe deficits in these two spatial tasks and were not able to distinguish the new or displaced object. For the
no-reactivation procedures, NaCl- but also propranolol-injected mice showed similar preference for the familiar or non-displaced object as compared to the new or
displaced object in the object recognition (NaCl: n = 7; Propranolol: n = 8; E) and object location (NaCl: n = 8; Propranolol: n = 9; H) tasks respectively. ##p < 0.01;
###p < 0.001 index vs. chance level; 50%. ∗∗∗p < 0.001 NaCl vs. Propranolol; NS, non significant.
propranolol mice exhibited an exploratory preference index that
was clearly different from chance level (50%; NaCl: 63.714 ±
4.04%; p < 0.001; Propranolol: 61.541 ± 5.13%; p < 0.001).
Thus, in this new behavioral task, propranolol mice presented no
memory deficit contrary to the classic version of the task.
Aquatic Object Location
To verify this result, we performed an object location task in the
swimming pool. In this task (Figures 5B,D), repeated measures
ANOVA for the latency to find the hidden platform during
acquisition revealed a significant session effect [η2p = 0.485;
F(3,42) = 19.664; p < 0.001] but no pre-treatment effect
[F(1,14) = 0.284; p = 0.602], nor session pre-treatment interaction
[F(3,42) = 0.184; p = 0.907]. An ANOVA conducted on the latency
to reach the platform during the reactivation trial also did not
reveal any pre-treatment effect [F(1,14) = 0.457; p = 0.510]. These
data confirmed that, in general, before treatment all groups of
mice learned the position of the platform and displayed the same
level of performance during the four learning sessions.
During PT (Figure 5F), all mice cross significantly more
time below the object that had remained in a familiar location
than the object that had been introduced to a new location.
ANOVA on the preference index revealed no treatment effect
[F(1,14) = 0.242; p = 0.630]. Control and propranolol mice
exhibited an exploratory preference index that was clearly
different from chance level (50%; NaCl: 75.399 ± 9.47%;
p < 0.001; Propranolol: 81.063 ± 6.50%; p < 0.001). Again,
propranolol mice presented no memory deficit contrary to the
classic version of the object location task.
DISCUSSION
Results from classic behavioral tasks are summarized in Table 1.
In these series of experiments, propranolol treatment induced
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FIGURE 5 | Propranolol does not impair memory reconsolidation in the aquatic object recognition and object location tasks. Schematics of the
behavioral protocols of the aquatic object recognition (A) and object location (B) tasks. Throughout training sessions, mice learned equally well to find the hidden
platform and exhibited decreasing latencies (±SEM) over blocks of trials in the aquatic object recognition (C) and location (D) tasks. Performances during PT are
expressed as the group mean (±SEM) preference index. The horizontal line represents equal exploration of the two objects. (E) For reactivation procedure of the
aquatic version of the object recognition task, NaCl- but also propranolol-injected mice showed similar preference for the familiar object as compared to the new
object (n = 11 per group). (F) For reactivation procedure of the aquatic version of the object location task, we obtained the same behavioral profile i.e., the two
groups of mice spent significantly more time below the object that had remained in a familiar location than the object that had been introduced to a new location
(n = 8 per group). ###p < 0.001 index vs. chance level; 50%.
amnesia if injected during both the consolidation and the
reconsolidation phases of the object recognition and object
location tasks, only on memory reconsolidation in the passive
avoidance and in the CTA tasks and never in MWM regardless
of the procedures used.
First, we compared within a single study the effect of
propranolol on memory consolidation and reconsolidation.
In this case, impairing the noradrenergic system with
propranolol was more efficient for reconsolidation than for
consolidation. Indeed, in aversive tasks, propranolol affected
only reconsolidation as it was already described in a passive
avoidance task (Przybyslawski et al., 1999) and auditory
fear conditioning (De
‘
biec and LeDoux, 2004). Considering
the involvement of the noradrenergic signaling in both
consolidation and reconsolidation (Rodrigues et al., 2009),
it is surprising that the effect of propranolol appears more robust
after reactivation than after the initial acquisition. Moreover,
in the two non-aversive object tasks, it was not the case and
a clear effect was found both on initial memory consolidation
and reconsolidation. One hypothesis advanced by De
‘
biec and
LeDoux (2004) is that ‘‘consolidation of aversive task involves
higher intensity of noradrenergic transmission because the
negative reinforcement is present and thus requires higher doses of
a β-receptor antagonist than other tasks, or other test conditions,
such as reconsolidation’’. Thus, the dose of propranolol that
effectively blocks memory reconsolidation may not be sufficient
to block consolidation (De
‘
biec and LeDoux, 2004). However,
in some cases, propranolol can affect consolidation with a low
dose (5 mg/kg) in a mildly stressful task (Cahill et al., 2000). In
our experiments, injections were always performed immediately
after the end of acquisition or after reactivation. However, the
duration of the reactivation was always very short (less than
3 min) but the duration of the training ranged between 15 s
for the passive avoidance to 75 min for the MWM. As there
are substantial timing effects of the noradrenergic signaling
on consolidation (Joëls et al., 2011), maybe the post-training
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TABLE 1 | Summary of the behavioral results.
Conditioned Passive Morris Morris Object Object
taste avoidance water maze water maze recognition location
aversion 19◦C 23◦C
Consolidation No effect No effect No effect No effect Effect Effect
Reconsolidation Effect Effect No effect No effect Effect Effect
Aversive task +++ +++ ++ + 0 0
Spatial task No No Yes Yes No Yes
Associative task Yes Yes Yes Yes No No
For each task, the level of aversiveness (from 0 neutral to +++ very aversive), as well as whether the task is spatial and/or associative is indicated.
injections of propranolol were too slow to block the fast
noradrenergic effects on consolidation whereas post-reactivation
injections were still sufficiently quick because of the short
reactivation session. Nevertheless, in the present study we found
no effect of propranolol injection on memory consolidation in
the shortest acquisition task (i.e., the passive avoidance task).
Another explanation is that noradrenergic transmission may
not be necessary for consolidation, but might be critical for
retrieval of aversive task (Murchison et al., 2004). However,
some studies reported an amnesic effect of propranolol injection
during consolidation in the passive avoidance (Gallagher et al.,
1977), in the MWM (Cahill et al., 2000) and in the object
recognition (Conversi et al., 2014) tasks. Discrepancies exist
in the literature as other studies found exactly the opposite in
the same behavioral tasks (Lalumiere et al., 2004; Telegdy et al.,
2005; Dornelles et al., 2007; Row and Dohanich, 2008; Okamura
et al., 2011; Palotai et al., 2014; and for review, see Roozendaal
and McGaugh, 2011).
In all cases, we highlighted the greatest sensibility of the
reconsolidation phase to the blockage of the noradrenergic
system by the propranolol that strengthens the interest to focus
on the reconsolidation process in a therapeutic strategy.
The second objective was to determine the type of memory
affected by the propranolol treatment. In the majority of
reconsolidation studies, authors have used aversive tasks as
passive avoidance or fear conditioning. Using the first task,
Przybyslawski et al. (1999) described a clear amnesic effect
of propranolol, however, it was not the case in the study
by Muravieva and Alberini (2010). Most of fear conditioning
studies reported an important memory impairment induced by
propranolol injection in both the contextual and the cued fear
conditioning (De
‘
biec and LeDoux, 2004; Abrari et al., 2008;
Muravieva and Alberini, 2010) whereas some others did not
(Gazarini et al., 2013; Vetere et al., 2013) depending on the
protocol or procedures used. The very few studies that have
used non-aversive tasks revealed a propranolol-induced amnesia
both in the radial maze (Przybyslawski et al., 1999) and in the
object recognition task (Liu et al., 2015). In the present work,
in comparable experimental conditions in the classic procedures
and with the same mouse strain, we obtained a clear amnesia
in the most as well as in the least aversive tasks, and not
in a moderately aversive task. It is therefore not the level of
aversion that influences the effect of propranolol in memory
processes.
An alternative explanation is that the effect of propranolol
may be linked to the type of the behavioral tasks. The absence
of effect of β-adrenergic blocking on the MWM performances
may be explained by the spatial nature of this task. However,
propranolol affects spatial memory in the object location task.
Second, we used associative and non-associative tasks. Again,
this factor could not explain the effect of propranolol as in
associative tasks as passive avoidance or CTA, we found a
great effect, contrasting with the lack of effect in another
associative task such as the MWM (see Table 1). The lack
of effect of propranolol administered after reactivation may
reflect that reconsolidation is not impaired by propranolol,
but we cannot exclude that reactivation may fail to induce
reconsolidation in the first place. The different results across
experiments may reflect different degrees of success in inducing
reconsolidation by the various retrieval procedures. Indeed, it
has been argued and evidenced some boundary conditions to
induce reconsolidation, including a mismatch between memory
representation and currently experienced condition, a prediction
error or a need for memory updating in human (Sevenster
et al., 2012, 2013, 2014) as well as in animal (Lee, 2009; Alfei
et al., 2015; Exton-McGuinness et al., 2015). Nevertheless, we
observed here an effect of propranolol administration during
reactivation on passive avoidance, CTA, as well as in classic
object recognition and object location tasks, demonstrating that
reconsolidation can be blocked in the present experimental
conditions.
Concerning the classic MWM, the reactivation trial consisted
in an additional training trial, suggesting no prediction error
was generated during memory reactivation, so preventing maybe
the induction of reconsolidation. However, in our lab, using
exactly the same behavioral procedure used as the present
study (Artinian et al., 2007, 2008), we obtained a clear
amnesic effect with an injection of protein synthesis inhibitor
during reactivation. Thus, in our experimental condition, the
reactivation trial induced memory reconsolidation and despite
the longer duration of training and the multiple training trials
(i.e., a potential difference in memory strength), post reactivation
anisomycin impaired subsequent spatial memory performances.
However, we cannot completely exclude that propranolol did
not affect reconsolidation because the strength of memory and
mutiple training acquisition were different in the MWM from
another behavioral tasks.With all these data obtained in the same
experimental conditions, it is difficult to understand the real role
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of propranolol in memory consolidation and reconsolidation.
None of the factors studied (aversion level, spatial learning,
associative learning) seem to explain our behavioral outcomes.
However, the MWM is unique in that animals are forced to
behave that it is not the case for all other tests. For example,
in the object recognition task, maybe the mouse detected the
new object, but it was no longer attracted by its novelty. In this
case, despite the maintenance of a good contextual memory,
behavioral performances will be very poor.
To dissociate between memory problem (i.e., contextual
amnesia) and emotional state (i.e., memory valence,
detachment. . .), we developed an aquatic version of the object
recognition and the object location tasks. In these two new tasks,
the cognitive aspect was exactly the same (i.e., to differentiate
between a familiar and a new object or between the locations
of two identical objects respectively). However, animals were in
water and the only way to escape was to swim to the platform.
Thus, in these new procedures, animals were forced to behave.
Unlike classic procedures, propranolol injection during
memory reconsolidation had no effect on memory in the
object recognition and location tests performed in the aquatic
environment. Propranolol-injected mice therefore recognized
the familiar object or the familiar location, demonstrating that
the ability of dissociation was not affected by propranolol, and
so that this treatment did not have a direct effect on the memory
reconsolidation of the contextual part of the information.
Our results support data reported in healthy humans showing
that propranolol did not affect declarative memory associated
to the fear memory but must selectively affect its emotional
component (Kindt et al., 2009; Kroes et al., 2010; Schwabe
et al., 2013). However, recent data from our group (Lonergan
et al., 2013) suggests that an impairing effect can be obtained
on both types of memory although the effect of propranolol
on the contextual/declarative content seems to be modest in
magnitude. PTSD patients, after propranolol treatment, showed
a clear reduction of physiologic/emotional responses related
to the traumatic memory and almost 70% of patients no
longer met the diagnostic criteria for PTSD (Brunet et al.,
2011, 2014). In these healed patients, no notable deficit in
contextual memory was observed. They still remembered well
their traumatic experience, even when the patients were asked
to generate from scratch their trauma script at each treatment
session (A. Brunet, personal communication, Sept. 14, 2014).
Nevertheless, after treatment, there was considerably less distress
or negative emotion during the evocation of the traumatic event,
as if the patients were now ‘‘emotionally detached’’ from those
memories.
Even if we cannot rule out the possible lack of reconsolidation
occurence in these experimental conditions, one hypothesis
to explain our results in animals is that propranolol may
specifically disrupt the reconsolidation of the emotional part
of the memory as in human. In this case, no more negative
or positive value was associated with the task. Thus, even if
propranolol-treatedmice remembered the task (intact contextual
memory), they would not have been attracted, or on the contrary
would have been repelled by the behavioral tests stimuli, unless
they were forced to perform, as it was the case in the water
environment. In the case of passive avoidance and CTA, the
disruption of the emotional memory would have made the dark
compartment and the saccharin less aversive for the treated
mice. Concerning the object recognition and locations tasks,
despite a good discrimination between the two different objects
or location, they would not be attracted anymore by their
novelty.
However, we have shown this specific effect of propranolol
injection on the emotional part of the memory trace only in
object tasks, and propranolol may perhaps have an overall effect
on memory reconsolidation in other behavioral tests. Moreover,
mice in the present study did not undergo any traumatic
stress before experiments and thus presented a normal basal
noradrenergic level. Given the noradrenergic dysfunction in
PTSD (Strawn and Geracioti, 2008), it would be interesting to
test the effectiveness of the different protocols of reactivation
associated with propranolol on mouse models of PTSD with
a noradrenergic hyperactivity. Even so, in human, propranolol
seems to affect memory in both healthy subjects (Kindt et al.,
2009) and patients suffering from PTSD (Brunet et al., 2011).
CONCLUSION
In this sudy, we have shown an action of propranolol
administration on the initial consolidation but most importantly
on thememory reconsolidation.Moreover, the observed amnesic
effect was not related to the aversion level of the task. This effect
seems due most likely to a modification of the emotional state of
the memory but leave the contextual component of the memory
undisturbed. From a treatment perspective and considering
the ethical criticisms generated by such an innovative strategy
affecting memory (Parens, 2010; Kass, 2003), this represents an
ideal state of affairs since most patients do not wish to have their
memories ‘‘erased’’ but rather wish they were no longer bothered
by them.
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